Pine Valley Investments LTD Liability CO Gilead Sciences, Inc. Transaction History
Pine Valley Investments LTD Liability CO
- $1.67 Trillion
- Q4 2024
A detailed history of Pine Valley Investments LTD Liability CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pine Valley Investments LTD Liability CO holds 2,501 shares of GILD stock, worth $265,005. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,501
Previous 2,495
0.24%
Holding current value
$265,005
Previous $209 Million
10.44%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,045Shares Held
1BCall Options Held
10MPut Options Held
9.05M-
Black Rock Inc. New York, NY121MShares$12.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.2 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.6 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.4 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.14 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $133B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...